Halobetasol Propionate is a synthetic glucocorticoid corticosteroid and a corticosteroid ester. It is a Group I corticosteroid under the US classification, the most potent class of such drugs.
Halobetasol propionate is usually supplied as a 0.05% topical cream and is the strongest topical steroid available. It is used to treat psoriasis and for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
US DMF was submitted to FDA on 23/09/2003 and the following number was assigned n. 16861.
Drug product containing Sterling’s Halobetasol Propionate is commercialized in USA.
Warning: Invalid argument supplied for foreach() in /srv/users/serverpilot/apps/sterling2019/public/wp-content/themes/sterling/single.php on line 64